Diabetes Clinical Trials in Portland

Showing 21-40 of 197 trials

Effects of DPP-4 Inhibition on Triglycerides

NCT01527747

The purpose of this study is to test the effects of saxagliptin, a treatment for diabetes, on fasting and post-meal blood triglyceride (blood fat) levels.

Type 2 DiabetesHypertriglyceridemia

Oregon Health and Science University15 participantsStarted Jan 2012

Portland, Oregon, United States

COMPLETEDNA8.6 miles

Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator

NCT02787785

The MADIT S-ICD trial was designed to evaluate if subjects with a prior myocardial infarction, diabetes mellitus and a relatively preserved ejection fraction of 36-50% will have a survival benefit from receiving a subcutaneous implantable cardioverter defibrillator (S-ICD) when compared to those receiving conventional medical therapy. The trial enrollment was stopped in 2018 due to lower than expected enrollment, all subjects enrolled at that time were followed for approximately 5 years.

TachycardiaDiabetes MellitusCardiovascular Disease

Boston Scientific Corporation40 participantsStarted Apr 2017

Huntsville, Alabama, United States • Scottsdale, Arizona, United States • Jonesboro, Arkansas, United States +46 more locations

Effects of DPP-4 Inhibition on Triglycerides

Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator

Diabetes Trials in Other Cities

Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

MIRACLE of LIFE Study

Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin

Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System

A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)

Navigator 1.5 Accuracy Study

FreeStyle Libre 3 Continuous Glucose Monitoring System

Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes

Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D

Look AHEAD: Action for Health in Diabetes

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants

Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria

The Combined Portfolio Diet and Exercise Study

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)

Family Health History in Diverse Care Settings (FHH)

Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM

Other Conditions in Portland